First came debit cards you could swipe like a credit card. Then came cash-transferring services like PayPal and Venmo. That led to the near extinction of the paper check. But it’s still critical to ...

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

Labcorp Holdings (LH) has quietly outperformed many healthcare peers this year, and the stock’s recent move has investors asking whether steady earnings growth and diagnostics demand can keep driving ...

Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...

Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer the only blood test cleared by the U.S. Food and Drug Administration to aid ...

At-home testosterone test kits use a finger-prick blood sample, with results generally available within a week. Some companies also offer saliva-based tests, which are pain-free and easy to collect, ...

NEW YORK – Laboratory Corporation of America and Natera this week reached an agreement to settle their genetic testing patent infringement dispute. On Wednesday, US District Judge Gregory Williams for ...

Laboratory Corp. of America Holdings and Natera Inc. settled their dispute over patents covering cancer-detection technology on the fifth day of their jury trial earlier this month, according to a ...

A high-profile courtroom showdown over DNA sequencing patents has ended abruptly. Labcorp and Natera reached a midtrial settlement in a bitter dispute over genetic testing rights, halting a Delaware ...